NYSE:PFE - Pfizer Stock Price, News, & Analysis

Pfizer trades on the New York Stock Exchange (NYSE) under the ticker symbol "PFE."

Pfizer declared a quarterly dividend on Friday, December 14th. Investors of record on Friday, February 1st will be given a dividend of $0.36 per share on Friday, March 1st. This represents a $1.44 annualized dividend and a yield of 3.41%. The ex-dividend date is Thursday, January 31st. This is a boost from Pfizer's previous quarterly dividend of $0.34. View Pfizer's Dividend History.

Pfizer declared that its Board of Directors has initiated a stock repurchase program on Friday, December 14th 2018, which authorizes the company to buyback $10,000,000,000.00 in shares, according to EventVestor. This buyback authorization authorizes the company to reacquire up to 3.8% of its stock through open market purchases. Stock buyback programs are typically an indication that the company's leadership believes its stock is undervalued.

Pfizer Inc. (NYSE:PFE) issued its quarterly earnings data on Tuesday, January, 29th. The biopharmaceutical company reported $0.64 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $0.63 by $0.01. The biopharmaceutical company earned $13.98 billion during the quarter, compared to analyst estimates of $13.92 billion. Pfizer had a net margin of 20.79% and a return on equity of 26.02%. The firm's revenue for the quarter was up 2.0% compared to the same quarter last year. During the same period in the prior year, the business posted $0.62 EPS. View Pfizer's Earnings History.

Pfizer is scheduled to release their next quarterly earnings announcement on Tuesday, May 7th 2019. View Earnings Estimates for Pfizer.

Pfizer updated its FY19 earnings guidance on Tuesday, January, 29th. The company provided earnings per share guidance of $2.82-2.92 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $3.04. The company issued revenue guidance of $52-54 billion, compared to the consensus revenue estimate of $54.31 billion.Pfizer also updated its FY 2019 guidance to $2.82-2.92 EPS.

21 Wall Street analysts have issued 1 year price objectives for Pfizer's shares. Their forecasts range from $37.00 to $55.00. On average, they expect Pfizer's share price to reach $45.1111 in the next year. This suggests a possible upside of 6.7% from the stock's current price. View Analyst Price Targets for Pfizer.

21 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Pfizer in the last year. There are currently 1 sell rating, 13 hold ratings and 7 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Pfizer.

News headlines about PFE stock have trended somewhat positive on Wednesday, according to InfoTrie Sentiment Analysis. InfoTrie ranks the sentiment of media coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Pfizer earned a news sentiment score of 0.7 on InfoTrie's scale. They also assigned media stories about the biopharmaceutical company a news buzz of 7.0 out of 10, indicating that recent media coverage is likely to have an impact on the stock's share price in the near future.

Pfizer saw a decrease in short interest in February. As of February 28th, there was short interest totalling 138,180,124 shares, a decrease of 11.4% from the February 15th total of 155,954,614 shares. Based on an average daily trading volume, of 22,945,995 shares, the short-interest ratio is currently 6.0 days. Approximately 2.4% of the shares of the company are short sold. View Pfizer's Current Options Chain.

Some companies that are related to Pfizer include Johnson & Johnson (JNJ), Roche Holdings AG Basel (RHHBY), Merck & Co., Inc. (MRK), Novartis (NVS), Abbott Laboratories (ABT), Eli Lilly And Co (LLY), Novo Nordisk A/S (NVO), AbbVie (ABBV), Sanofi (SNY), AstraZeneca (AZN), GlaxoSmithKline (GSK), Bristol-Myers Squibb (BMY), Bayer (BAYRY), Celgene (CELG) and Shire (SHPG).

Based on aggregate information from My MarketBeat watchlists, some companies that other Pfizer investors own include AT&T (T), Johnson & Johnson (JNJ), General Electric (GE), Cisco Systems (CSCO), Intel (INTC), Verizon Communications (VZ), Bank of America (BAC), Exxon Mobil (XOM), Merck & Co., Inc. (MRK) and JPMorgan Chase & Co. (JPM).

Pfizer's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (7.78%), Oregon Public Employees Retirement Fund (1.68%), Northern Trust Corp (1.31%), Geode Capital Management LLC (1.26%), Bank of New York Mellon Corp (1.10%) and Norges Bank (0.97%). Company insiders that own Pfizer stock include Alexander R Mackenzie, Charles H Hill, Dawn Rogers, Douglas M Lankler, Frank A Damelio, Ian C Read, Kirsten Lund-Jurgensen, Laurie J Olson, Loretta V Cangialosi, Mikael Dolsten, Pfizer Inc, Rady A Johnson, Sally Susman and W Don Cornwell. View Institutional Ownership Trends for Pfizer.

PFE stock was sold by a variety of institutional investors in the last quarter, including Longview Partners Guernsey LTD, Bank of New York Mellon Corp, Nordea Investment Management AB, Barrow Hanley Mewhinney & Strauss LLC, Massachusetts Financial Services Co. MA, FMR LLC, American International Group Inc. and American Century Companies Inc.. Company insiders that have sold Pfizer company stock in the last year include Alexander R Mackenzie, Dawn Rogers, Douglas M Lankler, Frank A Damelio, Ian C Read, Kirsten Lund-Jurgensen, Laurie J Olson, Loretta V Cangialosi, Mikael Dolsten, Rady A Johnson, Sally Susman and W Don Cornwell. View Insider Buying and Selling for Pfizer.

PFE stock was purchased by a variety of institutional investors in the last quarter, including Oregon Public Employees Retirement Fund, Norges Bank, BlackRock Inc., Geode Capital Management LLC, Northern Trust Corp, California Public Employees Retirement System, Railway Pension Investments Ltd and Bessemer Group Inc.. View Insider Buying and Selling for Pfizer.

Shares of PFE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of PFE stock can currently be purchased for approximately $42.27.

Pfizer has a market capitalization of $251.63 billion and generates $53.65 billion in revenue each year. The biopharmaceutical company earns $11.15 billion in net income (profit) each year or $3.00 on an earnings per share basis. Pfizer employs 92,400 workers across the globe.

The official website for Pfizer is http://www.pfizer.com.

Pfizer's mailing address is 235 EAST 42ND STREET, NEW YORK NY, 10017. The biopharmaceutical company can be reached via phone at 212-733-2323.